Ceylon Hospitals : Quarterly Financial Statements as of 31 December 2022

Financial Statements

Ceylon Hospitals PLC

For the 3rd Quarter ended 31st December 2022

CEYLON HOSPITALS PLC

				Financial Statements for the Nine Months ended 31st December 2022
Consolidated Statement of Profit or Loss and Other Comprehensive Income			Accumulated Period of 09 Months
	Group	Company	Group	Company
	03 Months	03 Months	03 Months	03 Months	09 Months	09 Months	09 Months	09 Months
	Ended	Ended	Ended	Ended	Ended	Ended	Ended	Ended
	31/12/2022	31/12/2021	31/12/2022	31/12/2021	31/12/2022	31/12/2021	31/12/2022	31/12/2021
	Rs. '000	Rs. '000	Rs. '000	Rs. '000	Rs. '000	Rs. '000	Rs. '000	Rs. '000
Revenue	2,174,592	1,834,290	1,200,065	1,212,531	5,754,409	5,814,828	3,196,506	3,902,302
Cost of Sales	(928,225)	(632,769)	(551,034)	(404,696)	(2,334,557)	(2,110,634)	(1,374,121)	(1,475,777)
Gross Profit	1,246,367	1,201,521	649,031	807,835	3,419,852	3,704,195	1,822,385	2,426,525
Other Operating Income	14,910	19,235	11,975	10,736	50,575	43,716	35,964	27,045
Administrative Expenses	(747,147)	(648,754)	(444,318)	(429,650)	(2,035,387)	(2,158,958)	(1,268,080)	(1,534,024)
Other Operating Expenses	(334,585)	(197,079)	(153,869)	(111,061)	(735,208)	(531,473)	(365,765)	(337,092)
Results from Operating Activities	179,545	374,924	62,819	277,860	699,832	1,057,480	224,504	582,454
Finance Cost	(24,516)	(19,092)	(15,137)	(16,811)	(54,842)	(59,560)	(39,691)	(56,058)
Finance Income	72,451	20,401	79,151	1,802	202,916	55,387	320,576	248,496
Gain on Bargain Purchase	-	-	-	-	-	12,002	-	-
Share of Profit of an Equity Accounted Investee	-	-	-	-	-	13,263	-	-
Profit before Taxation	227,480	376,233	126,833	262,852	847,906	1,078,571	505,389	774,893
Taxation	(142,941)	(55,320)	(93,849)	(28,863)	(266,584)	(233,876)	(120,725)	(117,519)
Net Profit after Taxation	84,539	320,913	32,984	233,988	581,322	844,695	384,664	657,374
Other Comprehensive Income
Items will not be reclassified to profit or loss
Net Change in Fair Value on Equity Investments at
FVTOCI	3,115	2,104	6,330	2,104	5,157	2,168	6,358	2,168
Deferred Tax on Revaluation Surplus	(283,571)		(283,571)		(283,571)	-	(283,571)	-
Other Comprehensive Income for the period	(280,456)	2,104	(277,241)	2,104	(278,414)	2,168	(277,213)	2,168
Total Comprehensive Income for the period	(195,917)	323,017	(244,257)	236,092	302,908	846,863	107,451	659,542
Profit Attributable to:
Equity Holders of the Parent	85,569	318,852	32,984	233,988	521,015	756,831	384,664	657,374
Non-Controlling Interest	(1,030)	2,061	-	-	60,307	87,864	-	-
	84,539	320,913	32,984	233,988	581,322	844,695	384,664	657,374

Total Comprehensive Income Attributable to: Equity Holders of the Parent Non-Controlling Interest

Earnings per Share - Basic

(194,281)	320,956	(244,257)	236,092	242,828	758,999	107,451	659,542
(1,636)	2,061	-	-	60,080	87,864	-	-
(195,917)	323,017	(244,257)	236,092	302,908	846,863	107,451	659,542
2.53	9.41	0.97	6.91	15.38	22.34	11.36	19.41

The above figures are provisional and subject to audit.

-1-

CEYLON HOSPITALS PLC

Financial Statements for the Nine Months ended 31st December 2022

Consolidated Statement of Financial Position
GROUP	COMPANY		GROUP	COMPANY
Audited	Audited		Unaudited	Unaudited	Unaudited	Unaudited
As at	As at		As at	As at	As at	As at
31/03/2022	31/03/2022		31/12/2022	31/12/2021	31/12/2022	31/12/2021
Rs. '000	Rs. '000		Rs. '000	Rs. '000	Rs. '000	Rs. '000
		ASSETS
		Non-Current Assets
8,481,203	5,592,128	Property, Plant and Equipment	9,753,828	8,190,051	6,699,899	5,417,958
288,954	288,954	Right of Use Assets	289,163	293,283	285,662	293,283
-	1,457,821	Investments in Subsidiary	-	-	1,457,821	1,457,821
272,923	71,416	Other Financial Assets	307,697	343,835	80,439	71,267
890	-	Prepaid Rent	-	579	-	-
9,043,970	7,410,319		10,350,688	8,827,748	8,523,821	7,240,329
		Current Assets
835,149	693,571	Inventories	985,534	679,882	786,164	553,293
306,454	214,955	Trade and Other Receivables	354,018	331,578	188,794	180,385
252,441	195,053	Prepayments	816,796	240,561	563,880	179,841
1,934	75,921	Amount Due from Related Parties	10,553	4,036	49,208	111,931
1,451,388	659,287	Other Financial Assets	843,175	958,820	66,532	149,524
13,278	13,259	Tax Refund Due	13,259	-	13,259	-
898,189	129,295	Cash and Cash Equivalents	384,111	772,382	230,238	129,181
3,758,833	1,981,341		3,407,446	2,987,258	1,898,075	1,304,155
12,802,803	9,391,660	Total Assets	13,758,134	11,815,006	10,421,896	8,544,484
		EQUITY AND LIABILITIES
		Equity Attributable to Equity holders of the parent
916,366	916,366	Stated Capital	916,366	916,366	916,366	916,366
2,691,662	2,134,544	Revaluation Reserve	2,408,091	2,691,662	1,850,973	2,134,544
65,868	600	Fair Value Reserve	71,252	70,604	6,958	2,296
3,873,950	2,695,436	Revenue Reserves	4,225,601	3,599,877	2,910,736	2,535,381
7,547,846	5,746,946		7,621,310	7,278,509	5,685,033	5,588,587
734,254	-	Non-Controlling Interests	711,004	693,439	-	-
8,282,100	5,746,946	Total Equity	8,332,314	7,971,948	5,685,033	5,588,587
		Non-Current Liabilities
1,701,501	1,606,247	Interest Bearing Loans and Borrowings	2,020,564	1,043,665	1,871,676	936,891
-	31,470	Deferred Revenue	-	-	27,442	32,254
177,998	156,790	Retirement Benefit Obligations	185,488	243,888	164,207	218,177
707,793	452,599	Deferred Tax Liabilities	1,078,076	652,562	808,623	440,809
2,587,292	2,247,106		3,284,128	1,940,116	2,871,948	1,628,131
		Current Liabilities
246,765	94,527	Bank Overdraft	312,550	181,775	217,252	92,213
306,060	248,830	Interest Bearing Loans and Borrowings	333,893	336,426	248,830	279,255
1,247,893	862,449	Trade and Other Payables	1,337,306	1,243,629	884,680	796,223
127,894	73,281	Taxation Payable	105,550	129,049	19,372	66,615
4,799	118,521	Amount Due to Related Parties	52,393	12,064	494,781	93,460
1,933,411	1,397,608		2,141,692	1,902,942	1,864,915	1,327,765
12,802,803	9,391,660	Total Equity and Liabilities	13,758,134	11,815,006	10,421,896	8,544,484

The above figures are provisional and subject to audit.

Sgd

Thusitha Rubasinghe

Chief Financial Officer

The Board of Directors is responsible for the preparation and presentation of these Financial Statements.

Signed for and on behalf of the Board by,

Sgd	Sgd
A E Tudawe	U D Tudawe
Chairman	Director
13th February 2023
	- 2 -

CEYLON HOSPITALS PLC

Consolidated Statement of Changes in Equity

Group

Balance as at 31st March 2021

Net Profit for the Year

Other Comprehensive Income

Actuarial Gain on Gratuity Valuation

Deferred Tax effect on Gratuity Valuation

Prior Year Adjustments - Inventory Written-off

Net Change in Fair Value on Equity Investments at FVTOCI

Share Buyback

Total Comprehensive Income for the Year

Transactions with Owners in their capacity as Owners

Non-Controlling Interest on Acquisition of Subsidiary

Dividend Paid - Ordinary Shares

Balance as at 31st March 2022

Net Profit for the Nine months ended 31 December 2022

Other Comprehensive Income

Net Change in Fair Value on Equity Investments at FVTOCI

Deferred Tax Effect on Revaluation Surplus

Total Comprehensive Income for the Nine Months Ended 31 December 2022

Transactions with Owners in their capacity as Owners

Shares issued at Rights Issue by subsidiary

Dividend Paid - Ordinary Shares

Balance as at 31st December 2022

Company

Balance as at 31st March 2021

Net Profit for the Year

Other Comprehensive Income

Actuarial Gain on Gratuity Valuation

Deferred Tax Effect on Gratuity Valuation

Net Change in Fair Value on Equity Investments at FVTOCI

Total Comprehensive Income for the Year

Transactions with Owners in their capacity as Owners

Dividend Paid - Ordinary Shares

Balance as at 31st March 2022

Net Profit for the Nine months ended 31 December 2022

Other Comprehensive Income

Net Change in Fair Value on Equity Investments at FVTOCI

Deferred Tax Effect on Revaluation Surplus

Total Comprehensive Income for the Nine Months ended 31 December 2022

Transactions with Owners in their capacity as Owners

Dividend Paid - Ordinary Shares

Balance as at 31st December 2022

			Financial Statements for the Nine Months ended 31st December 2022
	Attributable to equity holders of the parent
Stated	Revaluation	Fair Value	Revenue	Total	Non-Controlling	Total
Capital	Reserve	Reserve	Reserves		Interests	Equity
Rs. '000	Rs. '000	Rs. '000	Rs. '000	Rs. '000	Rs. '000	Rs. '000
916,366	2,691,662	68,436	2,951,439	6,627,903	592,626	7,220,529
-	-	-	982,324	982,324	127,202	1,109,526
-	-	-	55,965	55,965	300	56,265
-	-	-	(6,342)	(6,342)	332	(6,010)
-	-	-	(989)	(989)	(230)	(1,219)
-	-	(2,568)	-	(2,568)	217	(2,351)
-	-	-	(54)	(54)	-	(54)
-	-	(2,568)	1,030,904	1,028,335	127,822	1,156,158
-	-	-	-	-	127,301	127,301
-	-	-	(108,393)	(108,393)	(113,495)	(221,888)
-	-	-	(108,393)	(108,393)	13,806	(94,587)
916,366	2,691,662	65,868	3,873,950	7,547,845	734,254	8,282,100
-	-	-	521,015	521,015	60,307	581,322
-	-	5,384	-	5,384	(227)	5,157
-	(283,571)	-	-	(283,571)	-	(283,571)
-	(283,571)	5,384	521,015	242,828	60,080	302,908
-	-	-	-	-	5,860	5,860
-	-	-	(169,364)	(169,364)	(89,190)	(258,554)
-	-	-	(169,364)	(169,364)	(83,330)	(252,694)
916,366	2,408,091	71,252	4,225,601	7,621,310	711,004	8,332,314
Stated	Revaluation	Fair Value	Revenue	Total
Capital	Reserve	Reserve	Reserves
Rs. '000	Rs. '000	Rs. '000	Rs. '000	Rs. '000
916,366	2,134,544	128	1,986,400	5,037,438
-	-	-	770,550	770,550
-	-	-	54,510	54,510
-	-	-	(7,631)	(7,631)
-	-	472	-	472
-	-	472	817,429	817,901
-	-	-	(108,393)	(108,393)
-	-	-	(108,393)	(108,393)
916,366	2,134,544	600	2,695,436	5,746,946
-	-	-	384,664	384,664
-	-	6,358	-	6,358
-	(283,571)	-	-	(283,571)
-	(283,571)	6,358	384,664	107,451
-	-	-	(169,364)	(169,364)
-	-	-	(169,364)	(169,364)
916,366	1,850,973	6,958	2,910,736	5,685,033

- 3-

CEYLON HOSPITALS PLC

Consolidated Statement of Changes in Equity

Group

Balance as at 31st March 2020

Net Profit for the Year

Other Comprehensive Income

Deferred Tax Effect on Revaluation Gain Actuarial Gain on Gratuity valuation Deferred Tax Effect on Gratuity valuation

Net Change in Fair Value on Equity Investments at FVTOCI

Total Comprehensive Income for the Year

Transactions with Owners in their capacity as Owners

Share of additional capital attributable to NCI

Dividend Paid - Ordinary Shares

Balance as at 31st March 2021

Net Profit for the nine months ended 31 December 2021

Other Comprehensive Income

Net Change in Fair Value on Equity Investments at FVTOCI

Total Comprehensive Income for the Nine months ended 31 December 2021 Transactions with Owners in their capacity as Owners

Non-Controlling Interest on Acquisition of Subsidiary

Dividend Paid - Ordinary Shares

Balance as at 31st December 2021

Company

Balance as at 31st March 2020

Net Profit for the Year

Other Comprehensive Income

Deferred Tax Effect on Revaluation Gain Actuarial Gain on Gratuity valuation Deferred Tax Effect on Gratuity valuation

Net Change in Fair Value on Equity Investments at FVTOCI

Total Comprehensive Income for the Year

Transactions with Owners in their capacity as Owners

Dividend Paid - Ordinary Shares

Balance as at 31st March 2021

Net Profit for the nine months ended 31 December 2021

Other Comprehensive Income

Net Change in Fair Value on Equity Investments at FVTOCI

Total Comprehensive Income for the Nine months ended 31 December 2021 Transactions with Owners in their capacity as Owners

Dividend Paid - Ordinary Shares

Balance as at 31st December 2021

Financial Statements for the Nine Months ended 31st December 2022

	Attributable to equity holders of the parent
Stated	Revaluation	Fair Value	Revenue	Total	Non Controlling	Total
Capital	Reserve	Reserve	Reserves		Interests	Equity
Rs. '000	Rs. '000	Rs. '000	Rs. '000	Rs. '000	Rs. '000	Rs. '000
916,366	2,483,785	65,922	2,439,753	5,905,826	587,760	6,493,586
-	-	-	560,349	560,349	39,910	600,259
-	207,877	-	-	207,877	752	208,629
-	-	-	32,865	32,865	370	33,235
-	-	-	(7,007)	(7,007)	(610)	(7,617)
-	-	2,514	-	2,514	554	3,068
-	207,877	2,514	586,206	796,597	40,975	837,572
-	-	-	-	-	1,750	1,750
-	-	-	(74,520)	(74,520)	(37,859)	(112,379)
-	-	-	(74,520)	(74,520)	(36,109)	(110,629)
916,366	2,691,662	68,436	2,951,439	6,627,903	592,626	7,220,530
-	-	-	756,831	756,831	87,864	844,695
-	-	2,168	-	2,168	-	2,168
-	-	2,168	756,831	758,999	87,864	846,863
-	-	-	-	-	126,444	126,444
-	-	-	(108,393)	(108,393)	(113,496)	(221,888)
-	-	-	(108,393)	(108,393)	12,948	(95,444)
916,366	2,691,662	70,604	3,599,877	7,278,509	693,439	7,971,948
Stated	Revaluation	Fair Value	Revenue	Total
Capital	Reserve	Reserve	Reserves
Rs. '000	Rs. '000	Rs. '000	Rs. '000	Rs. '000
916,366	1,931,063	-	1,588,064	4,435,493
-	-	-	446,118	446,118
-	203,481	-	-	203,481
-	-	-	31,090	31,090
-	-	-	(4,353)	(4,353)
-	-	128	-	128
-	203,481	128	472,855	676,464
-	-	-	(74,520)	(74,520)
-	-	-	(74,520)	(74,520)
916,366	2,134,544	128	1,986,400	5,037,438
-	-	-	657,374	657,374
-	-	2,168	-	2,168
-	-	2,168	657,374	659,542
-	-	-	(108,393)	(108,393)
-	-	-	(108,393)	(108,393)
916,366	2,134,544	2,296	2,535,381	5,588,587

- 4 -